| Date | Time | Source | Headline | Symbol | Company |
| 01/24/2019 | 7:08AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 01/24/2019 | 7:06AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 01/24/2019 | 7:01AM | GlobeNewswire Inc. | Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage ... | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 01/24/2019 | 5:07AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 01/24/2019 | 5:06AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 01/16/2019 | 4:32PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 01/16/2019 | 4:30PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 01/15/2019 | 6:00AM | GlobeNewswire Inc. | Apricus Biosciences Stockholders Approve Proposed Merger with Seelos Therapeutics, Inc. | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 01/04/2019 | 5:05PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 01/04/2019 | 4:58PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 01/04/2019 | 11:08AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 12/26/2018 | 3:12PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 12/17/2018 | 5:15AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 12/17/2018 | 5:15AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 12/17/2018 | 5:10AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 12/14/2018 | 3:49PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 12/14/2018 | 3:47PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 12/14/2018 | 11:30AM | GlobeNewswire Inc. | Apricus Biosciences Adjourns Special Meeting of Stockholders to New Date | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 12/10/2018 | 6:00AM | GlobeNewswire Inc. | Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018 | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 12/06/2018 | 7:08AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 11/30/2018 | 7:02AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 11/21/2018 | 5:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 11/20/2018 | 4:23PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 11/20/2018 | 3:11PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 11/16/2018 | 4:33PM | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 11/16/2018 | 3:16PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 11/16/2018 | 3:15PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 10/31/2018 | 3:37PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 10/31/2018 | 3:36PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 10/31/2018 | 3:24PM | GlobeNewswire Inc. | Apricus Biosciences Provides Corporate Update and Third Quarter 2018 Financial Results | NASDAQ:APRI | Apricus Biosciences, Inc. |